Evaluation of Richmond Agitation Sedation Scale According to Alveolar Concentration of Sevoflurane During a Sedation With Sevoflurane in ICU Patients

• Status: Completed
• Trial end date: 2014-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Describe the Richmond Agitation Sedation Scale (RASS) values corresponding to the values of Minimum alveolar concentration of sevoflurane during sedation of patients in ICU

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Clermont-Ferrand
• Treatments: Sevoflurane

Criteria

Inclusion Criteria:

• Requiring sedation by sevoflurane in ICU

• Adult patients

• Patients covered by french health care system

• Patients who have given their consent or his family

Exclusion Criteria:

• Pregnant or lactating women

• Sevoflurane anaphylaxia

• Known or suspected risk of malignant hyperthermia

• Refusal Protocol

• Brain-damaged patients

• Hemodynamic conditions not compatible with the use of sevoflurane

• ARDS patients

• Minor patients